NEW YORK (GenomeWeb) – Biodesix today announced that Health Net has issued a positive coverage decision for the VeriStrat test. 

According to Biodesix, Health Net considers the test medically necessary for patients with advanced non-small cell lung cancer and wild-type EGFR or with unknown EGFR status. Health Net covers about 5.9 million lives, primarily on the US West Coast. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Under a proposed spending bill, the US National Institutes of Health would see an additional $3 billion in funding.

Researchers from the University of Oxford and the University of Sydney sequenced numerous platypus genomes to study their population history.

Robert Redfield, the new pick to lead the US Centers for Disease Control and Prevention, has faced criticism for some of his work.

In Nature this week: sequenced genomes of five additional Neanderthals, and more.